Report Detail
Global Gene Engineered Subunit Vaccine Market Size, Status and Forecast 2020-2026
- RnM3946645 |
- 13 April, 2020 |
- Global |
- 94 Pages |
- QYResearch |
- Medical Industry
A gene engineered subunit vaccine or a bio-recombinant subunit vaccine refers to the expression of a protective antigen gene in a prokaryotic or eukaryotic cell, and a vaccine made from a gene product—protein or polypeptide.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Gene Engineered Subunit Vaccine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Gene Engineered Subunit Vaccine industry.
Based on our recent survey, we have several different scenarios about the Gene Engineered Subunit Vaccine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Gene Engineered Subunit Vaccine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Engineered Subunit Vaccine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Engineered Subunit Vaccine market in terms of revenue.
Players, stakeholders, and other participants in the global Gene Engineered Subunit Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Gene Engineered Subunit Vaccine market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Gene Engineered Subunit Vaccine market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Engineered Subunit Vaccine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Engineered Subunit Vaccine market.
The following players are covered in this report:
Merck
GSK
Tiantan
Pulike
Greffex
CureVac
Yebio
Sanofi Pasteur SA
Virbac
Pfizer Inc.
Walvax Biotechnology
Kontec
Gene Engineered Subunit Vaccine Breakdown Data by Type
Therapeutic Gene Engineered Subunit Vaccine
Preventative Gene Engineered Subunit Vaccine
Gene Engineered Subunit Vaccine Breakdown Data by Application
Human Use
Veterinary Use
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by Gene Engineered Subunit Vaccine Revenue
- 1.4 Market Analysis by Type
- 1.4.1 Global Gene Engineered Subunit Vaccine Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Therapeutic Gene Engineered Subunit Vaccine
- 1.4.3 Preventative Gene Engineered Subunit Vaccine
- 1.5 Market by Application
- 1.5.1 Global Gene Engineered Subunit Vaccine Market Share by Application: 2020 VS 2026
- 1.5.2 Human Use
- 1.5.3 Veterinary Use
- 1.6 Coronavirus Disease 2019 (Covid-19): Gene Engineered Subunit Vaccine Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Gene Engineered Subunit Vaccine Industry
- 1.6.1.1 Gene Engineered Subunit Vaccine Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Gene Engineered Subunit Vaccine Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Gene Engineered Subunit Vaccine Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Gene Engineered Subunit Vaccine Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Global Growth Trends by Regions
- 2.1 Gene Engineered Subunit Vaccine Market Perspective (2015-2026)
- 2.2 Gene Engineered Subunit Vaccine Growth Trends by Regions
- 2.2.1 Gene Engineered Subunit Vaccine Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Gene Engineered Subunit Vaccine Historic Market Share by Regions (2015-2020)
- 2.2.3 Gene Engineered Subunit Vaccine Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 Gene Engineered Subunit Vaccine Market Growth Strategy
- 2.3.6 Primary Interviews with Key Gene Engineered Subunit Vaccine Players (Opinion Leaders)
3 Competition Landscape by Key Players
- 3.1 Global Top Gene Engineered Subunit Vaccine Players by Market Size
- 3.1.1 Global Top Gene Engineered Subunit Vaccine Players by Revenue (2015-2020)
- 3.1.2 Global Gene Engineered Subunit Vaccine Revenue Market Share by Players (2015-2020)
- 3.1.3 Global Gene Engineered Subunit Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global Gene Engineered Subunit Vaccine Market Concentration Ratio
- 3.2.1 Global Gene Engineered Subunit Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by Gene Engineered Subunit Vaccine Revenue in 2019
- 3.3 Gene Engineered Subunit Vaccine Key Players Head office and Area Served
- 3.4 Key Players Gene Engineered Subunit Vaccine Product Solution and Service
- 3.5 Date of Enter into Gene Engineered Subunit Vaccine Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Gene Engineered Subunit Vaccine Historic Market Size by Type (2015-2020)
- 4.2 Global Gene Engineered Subunit Vaccine Forecasted Market Size by Type (2021-2026)
5 Gene Engineered Subunit Vaccine Breakdown Data by Application (2015-2026)
- 5.1 Global Gene Engineered Subunit Vaccine Market Size by Application (2015-2020)
- 5.2 Global Gene Engineered Subunit Vaccine Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Gene Engineered Subunit Vaccine Market Size (2015-2020)
- 6.2 Gene Engineered Subunit Vaccine Key Players in North America (2019-2020)
- 6.3 North America Gene Engineered Subunit Vaccine Market Size by Type (2015-2020)
- 6.4 North America Gene Engineered Subunit Vaccine Market Size by Application (2015-2020)
7 Europe
- 7.1 Europe Gene Engineered Subunit Vaccine Market Size (2015-2020)
- 7.2 Gene Engineered Subunit Vaccine Key Players in Europe (2019-2020)
- 7.3 Europe Gene Engineered Subunit Vaccine Market Size by Type (2015-2020)
- 7.4 Europe Gene Engineered Subunit Vaccine Market Size by Application (2015-2020)
8 China
- 8.1 China Gene Engineered Subunit Vaccine Market Size (2015-2020)
- 8.2 Gene Engineered Subunit Vaccine Key Players in China (2019-2020)
- 8.3 China Gene Engineered Subunit Vaccine Market Size by Type (2015-2020)
- 8.4 China Gene Engineered Subunit Vaccine Market Size by Application (2015-2020)
9 Japan
- 9.1 Japan Gene Engineered Subunit Vaccine Market Size (2015-2020)
- 9.2 Gene Engineered Subunit Vaccine Key Players in Japan (2019-2020)
- 9.3 Japan Gene Engineered Subunit Vaccine Market Size by Type (2015-2020)
- 9.4 Japan Gene Engineered Subunit Vaccine Market Size by Application (2015-2020)
10 Southeast Asia
- 10.1 Southeast Asia Gene Engineered Subunit Vaccine Market Size (2015-2020)
- 10.2 Gene Engineered Subunit Vaccine Key Players in Southeast Asia (2019-2020)
- 10.3 Southeast Asia Gene Engineered Subunit Vaccine Market Size by Type (2015-2020)
- 10.4 Southeast Asia Gene Engineered Subunit Vaccine Market Size by Application (2015-2020)
11 India
- 11.1 India Gene Engineered Subunit Vaccine Market Size (2015-2020)
- 11.2 Gene Engineered Subunit Vaccine Key Players in India (2019-2020)
- 11.3 India Gene Engineered Subunit Vaccine Market Size by Type (2015-2020)
- 11.4 India Gene Engineered Subunit Vaccine Market Size by Application (2015-2020)
12 Central & South America
- 12.1 Central & South America Gene Engineered Subunit Vaccine Market Size (2015-2020)
- 12.2 Gene Engineered Subunit Vaccine Key Players in Central & South America (2019-2020)
- 12.3 Central & South America Gene Engineered Subunit Vaccine Market Size by Type (2015-2020)
- 12.4 Central & South America Gene Engineered Subunit Vaccine Market Size by Application (2015-2020)
13Key Players Profiles
- 13.1 Merck
- 13.1.1 Merck Company Details
- 13.1.2 Merck Business Overview and Its Total Revenue
- 13.1.3 Merck Gene Engineered Subunit Vaccine Introduction
- 13.1.4 Merck Revenue in Gene Engineered Subunit Vaccine Business (2015-2020))
- 13.1.5 Merck Recent Development
- 13.2 GSK
- 13.2.1 GSK Company Details
- 13.2.2 GSK Business Overview and Its Total Revenue
- 13.2.3 GSK Gene Engineered Subunit Vaccine Introduction
- 13.2.4 GSK Revenue in Gene Engineered Subunit Vaccine Business (2015-2020)
- 13.2.5 GSK Recent Development
- 13.3 Tiantan
- 13.3.1 Tiantan Company Details
- 13.3.2 Tiantan Business Overview and Its Total Revenue
- 13.3.3 Tiantan Gene Engineered Subunit Vaccine Introduction
- 13.3.4 Tiantan Revenue in Gene Engineered Subunit Vaccine Business (2015-2020)
- 13.3.5 Tiantan Recent Development
- 13.4 Pulike
- 13.4.1 Pulike Company Details
- 13.4.2 Pulike Business Overview and Its Total Revenue
- 13.4.3 Pulike Gene Engineered Subunit Vaccine Introduction
- 13.4.4 Pulike Revenue in Gene Engineered Subunit Vaccine Business (2015-2020)
- 13.4.5 Pulike Recent Development
- 13.5 Greffex
- 13.5.1 Greffex Company Details
- 13.5.2 Greffex Business Overview and Its Total Revenue
- 13.5.3 Greffex Gene Engineered Subunit Vaccine Introduction
- 13.5.4 Greffex Revenue in Gene Engineered Subunit Vaccine Business (2015-2020)
- 13.5.5 Greffex Recent Development
- 13.6 CureVac
- 13.6.1 CureVac Company Details
- 13.6.2 CureVac Business Overview and Its Total Revenue
- 13.6.3 CureVac Gene Engineered Subunit Vaccine Introduction
- 13.6.4 CureVac Revenue in Gene Engineered Subunit Vaccine Business (2015-2020)
- 13.6.5 CureVac Recent Development
- 13.7 Yebio
- 13.7.1 Yebio Company Details
- 13.7.2 Yebio Business Overview and Its Total Revenue
- 13.7.3 Yebio Gene Engineered Subunit Vaccine Introduction
- 13.7.4 Yebio Revenue in Gene Engineered Subunit Vaccine Business (2015-2020)
- 13.7.5 Yebio Recent Development
- 13.8 Sanofi Pasteur SA
- 13.8.1 Sanofi Pasteur SA Company Details
- 13.8.2 Sanofi Pasteur SA Business Overview and Its Total Revenue
- 13.8.3 Sanofi Pasteur SA Gene Engineered Subunit Vaccine Introduction
- 13.8.4 Sanofi Pasteur SA Revenue in Gene Engineered Subunit Vaccine Business (2015-2020)
- 13.8.5 Sanofi Pasteur SA Recent Development
- 13.9 Virbac
- 13.9.1 Virbac Company Details
- 13.9.2 Virbac Business Overview and Its Total Revenue
- 13.9.3 Virbac Gene Engineered Subunit Vaccine Introduction
- 13.9.4 Virbac Revenue in Gene Engineered Subunit Vaccine Business (2015-2020)
- 13.9.5 Virbac Recent Development
- 13.10 Pfizer Inc.
- 13.10.1 Pfizer Inc. Company Details
- 13.10.2 Pfizer Inc. Business Overview and Its Total Revenue
- 13.10.3 Pfizer Inc. Gene Engineered Subunit Vaccine Introduction
- 13.10.4 Pfizer Inc. Revenue in Gene Engineered Subunit Vaccine Business (2015-2020)
- 13.10.5 Pfizer Inc. Recent Development
- 13.11 Walvax Biotechnology
- 10.11.1 Walvax Biotechnology Company Details
- 10.11.2 Walvax Biotechnology Business Overview and Its Total Revenue
- 10.11.3 Walvax Biotechnology Gene Engineered Subunit Vaccine Introduction
- 10.11.4 Walvax Biotechnology Revenue in Gene Engineered Subunit Vaccine Business (2015-2020)
- 10.11.5 Walvax Biotechnology Recent Development
- 13.12 Kontec
- 10.12.1 Kontec Company Details
- 10.12.2 Kontec Business Overview and Its Total Revenue
- 10.12.3 Kontec Gene Engineered Subunit Vaccine Introduction
- 10.12.4 Kontec Revenue in Gene Engineered Subunit Vaccine Business (2015-2020)
- 10.12.5 Kontec Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Gene Engineered Subunit Vaccine. Industry analysis & Market Report on Gene Engineered Subunit Vaccine is a syndicated market report, published as Global Gene Engineered Subunit Vaccine Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Gene Engineered Subunit Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
